Veteran Global Health Leader, Dr. Rebecca Martin, Named President of Global Immunization at Sabin
Martin most recently served as Vice President for Global Health at Emory University, and as the Director of the Emory Global Health Institute, following a 24-year career with the US Centers for Disease Control and Prevention (CDC). She is also an adjunct professor in the Department of Global Health at Emory. She brings decades of successful partnering with global, regional and country-level health leaders in infectious disease prevention, as well as in-country experience leading low- and middle-income country (LMIC) health and immunization initiatives.
Her extensive CDC career includes ten years working in Kenya, Tanzania, and Denmark, seconded to the World Health Organization African and European regions. In her four years in Nairobi, Kenya, she provided technical expertise to eight East African countries focused on vaccine-preventable disease surveillance, prevention and elimination strategies and policies, and new vaccine introductions. For several years in Dar as Salaam, Tanzania, she led surveillance and workforce development for CDC as part of the President's Emergency Plan for AIDS Relief (PEPFAR), and supervised staff in surveillance, health management information systems (HMIS), monitoring and evaluation (M&E), and human capacity development for CDC HIV/AIDS programs.
Currently, she serves as the Vice-Chair for WHO Regional Office for Africa (AFRO) Emergency Preparedness & Response Technical Advisory Group (EPR-TAG), an independent advisory group providing strategic guidance on all matters pertaining to public health emergency preparedness and response in Africa.
'With her global, country and local-level experience, Rebecca has the first-hand expertise needed to address today's challenging immunization landscape, and more importantly, to co-create new solutions with public and private partners to boost lagging immunization rates and prevent human suffering,' says Sabin CEO Amy Finan. 'She is an outstanding addition to Sabin's executive team and will lead Sabin's global immunization work as we continue to respond to the needs of individual countries and help shape new global strategies with partners to increase access and uptake of vaccines.'
Martin calls her new role a 'full circle' moment.
'I am honored and excited to join the Sabin Vaccine Institute as President of Global Immunization, bringing my experience, knowledge, and commitment to Sabin's critical mission in making vaccines available to everyone, everywhere,' she says.
'I am thrilled to work with the dedicated colleagues at Sabin who are passionate about tackling vaccine-preventable diseases through collaboration with stakeholders from multiple sectors in addition to health,' she adds. 'There is no moment more urgent than now to innovate and double down on our efforts to prevent illness and save lives through immunization.'
Sabin's Global Immunization team works with local and national governments and academic, global, and philanthropic partners to put communities at the heart of solutions that tackle urgent vaccination challenges, with a renewed focus to bolster the falling coverage in childhood routine immunization and support life-course immunization. In 2023, almost 14.5 million children received no vaccinations, according to WHO, an increase of 2.7 million more children compared to 2019.
The Sabin team brings expertise across the immunization spectrum, including building global communities of practice, identifying barriers and creating solutions to improve vaccine access and delivery of current and new vaccines, and conducting epidemiological research to support immunization. Sabin's skills are applied to multiple infectious diseases, including HPV, typhoid, cholera, rotavirus, COVID-19 and malaria. Additional work includes efforts to immunize zero-dose children and transition to hexavalent vaccines in national immunization programs.
During her tenure at Emory, Martin built and aligned multidisciplinary global health infrastructure, fostered global collaborations across health organizations, led interdisciplinary global health research and worked to build the next generation of global health leaders. She was also a member of Emory's Woodruff Health Sciences Center leadership team.
Martin's most recent role with the CDC was Director of the Center for Global Health, then the largest operating unit at the CDC. Her achievements include leading the CDC's global efforts across disease initiatives and through the start of the global health security agenda, including polio eradication and disease control acceleration and elimination for vaccine-preventable diseases, malaria elimination, ending HV epidemics, and strengthening health systems to detect and respond to disease threats and emergencies.
Martin received her Doctor of Philosophy from the Johns Hopkins Bloomberg School of Public Health in international health with a focus on infectious disease epidemiology. She has co-authored manuscripts and developed strategic plans, normative guidance and guidelines on immunization strategies, vaccine-preventable diseases and surveillance methods for both immunization and HIV, and for global health security.
About the Sabin Vaccine Institute
The Sabin Vaccine Institute is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation. Unlocking the potential of vaccines through partnership, Sabin has built a robust ecosystem of funders, innovators, implementers, practitioners, policy makers and public stakeholders to advance its vision of a future free from preventable diseases. As a nonprofit with three decades of experience, Sabin is committed to finding solutions that last and extending the full benefits of vaccines to all people, regardless of who they are or where they live. At Sabin, we believe in the power of vaccines to change the world. For more information, visit
www.sabin.org
and follow us on X @SabinVaccine.
Media Contact:
Monika Guttman
Senior Media Relations Specialist
Sabin Vaccine Institute
+1 (202) 621-1691
press@sabin.org
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/05fb30d1-3f58-4240-aafe-91d33dab3398
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
44 minutes ago
- Yahoo
A New COVID Variant Is Here, And It's More Transmissible — Here Are The Signs And Symptoms
A new COVID variant known as NB.1.8.1 has made landfall in the United States. As of late May, the variant, which was first detected in China this past January, accounted for 10% of the SARS-CoV-2 sequences tested from around the world, recent surveillance data found. That's a significant jump from 2.5% four weeks prior. A Centers for Disease Control and Prevention (CDC) spokesperson told HuffPost that the agency is in regular contact with international partners about the activity of NB.1.8.1. Up until late May, only 20 NB.1.8.1 sequences had been identified in the U.S. — that's below the threshold needed for a variant to appear on the agency's COVID dashboard. (As soon as its prevalence increases, NB.1.8.1 will pop up on the tracker, the spokesperson added.) It's nerve-wracking to hear that a new variant is making the rounds, but infectious disease specialists say there are no glaring differences between the symptoms of NB.1.8.1 and those caused by other versions of SARS-CoV-2. 'Currently it appears that NB.1.8.1 would have similar symptoms to other COVID variants that have recently been circulating,' Dr. Zachary Hoy, a pediatric infectious disease specialist with Pediatrix Medical Group in Nashville, Tennessee, told HuffPost. Here's what to know about the newest COVID variant that's gaining traction around the world. NB.1.8.1's mutations likely make it more transmissible. Compared to the currently dominant variant in the U.S. (LP.8.1), NB.1.8.1 has a handful of new mutations on the spike protein that may enhance its ability to bind to our cells, according to the World Health Organization (WHO). The agency suspects these mutations will increase the virus's transmissibility and, potentially, diminish the effectiveness of neutralizing antibodies that prevent pathogens from latching to our cells. In other words, the variant may be skilled at dodging some of our immune defenses, research suggests. Here are the signs and symptoms doctors are seeing with NB.1.8.1. According to Dr. Amesh Adalja, an infectious diseases expert and senior scholar at the Johns Hopkins University Center for Health Security, NB.1.8.1's symptoms are pretty much the same as those seen with other SARS-CoV-2 variants. Two of COVID's hallmark symptoms are a mild but persistent dry cough and nasal congestion, Hoy said. Many people who come down with COVID are also hit with fatigue and tiredness. 'An infected person can still make it through the day, but they are resting more and feel more tired throughout the day,' Hoy said. Other common symptoms include a fever, chills, a sore throat and muscle aches. 'Some have described recent variants as less intense symptoms as compared to wintertime influenza viruses, but both can have severe symptoms,' Hoy said. There's no evidence suggesting the variant causes more severe disease or an uptick in hospitalizations or deaths, the WHO states. The only noticeable aspect, as of now, is that it's rising in prevalence, Adalja said. How effective are the vaccines against NB.1.8.1? It's too early to know exactly how effective the shots are — as the research on NB.1.8.1 is limited since it's so new — but scientists expect the shots to hold up well. NB.1.8.1 broke off from the Omicron JN.1 lineage, which the 2024-2025 vaccines target. 'The ability of the vaccines to prevent severe illness is intact though protection versus infection is limited and transient,' Adalja said. Anyone who is at risk of severe disease should stay up-to-date with the shots. 'Those in older populations or with underlying immune disorders or on immune-decreasing medications would benefit more from vaccination or those with increased exposure such as healthcare workers,' Hoy added. So if you have a condition that puts you at risk, it's worth getting vaccinated if it's been more than six months since your last vaccine or bout of COVID, Adalja advises. He also added that those who are low-risk likely do not need to go out and get another shot. Know when to treat NB.1.8.1 at home and when to go visit a doctor. Most people will be able to recover at home by resting and staying hydrated. While you're sick, acetaminophen and ibuprofen can help alleviate muscle aches and fevers, Hoy said. And, in most cases, symptoms should clear up within a week. For those who are at risk for severe disease, including older adults and people who are immune-compromised, it's worth contacting a physician as they can prescribe antivirals — Paxlovid and Molnupiravir — that can significantly lower the risk of severe complications and death. As was the case with previous variants, these antivirals work best when started within five days of symptom onset. As for when you should go to an urgent care or emergency room? When you have chest pain, have a hard time waking up or staying awake, or feel confused and disoriented, the CDC advises. Hoy says the most concerning symptom he warns patients about is difficulty breathing. 'If you have COVID or COVID-like illness and have worsening trouble breathing or chest pain, you should be evaluated at your doctor's office, urgent care or the ER,' he said. Related... RFK Jr. Says COVID Shot Will No Longer Be Advised For Healthy Kids, Pregnant Women COVID Cases Are Rising This Summer, But Not All The Data Shows It — Here's Why People Are Reporting A Frightening COVID Symptom Right Now — Here's What To Know
Epoch Times
4 hours ago
- Epoch Times
At Least 85 People Sickened by THC at Wisconsin Pizza Place: CDC Report
Roughly nine months after an incident at a Wisconsin pizza parlor where marijuana-infused oil was used to prepare dough, the Centers for Disease Control and Prevention (CDC) released a report detailing how dozens of customers experienced symptoms consistent with THC intoxication. The report, released on July 24, describes how at least 85 people, from ages 1–91, ate food from the restaurant in Stoughton, Wisconsin, between Oct. 22 and 24, 2024, and experienced THC sickness. The restaurant was in a building with a cooperative, or shared kitchen, that was also used by a 'state-licensed vendor who produced edible THC products.'
Yahoo
10 hours ago
- Yahoo
The Silent Symptom That Could Be a Sign of Blood Clots
The Silent Symptom That Could Be a Sign of Blood Clots originally appeared on Parade. Your blood's ability to clot after a cut or injury is an important defense mechanism to keep you from bleeding too much. But blood clots can cause serious health issues like strokes and heart attacks when they happen outside of that. About 900,000 people in the U.S. develop a blood clot each year, according to the Centers for Disease Control and Prevention (CDC). An estimated 60,000 to 100,000 Americans die from blood clot complications annually, making this an important health issue to be aware of. 'Awareness of blood clot symptoms is critically important because early recognition can be life-saving,' says, a pulmonologist at The Ohio State University Wexner Medical Center. 'Recognizing symptoms early allows for prompt medical treatment.' That can help lower the risk of permanent damage to organs or tissues, he points the problem: Not all symptoms of blood clots are obvious, and one in particular can be easily mistaken for other, much less severe health issues. Here's what doctors want you to keep in mind about this symptom, why it can be confused with other things and when to take action. 🩺SIGN UP for tips to stay healthy & fit with the top moves, clean eats, health trends & more delivered right to your inbox twice a week💊 How Do Serious Blood Clots Happen? Before we go over the symptom, it's important to first go over how blood clots can become serious. Blood clots that happen spontaneously usually start in the legs, explains , a vascular surgeon at MemorialCare Orange Coast Medical Center in Fountain Valley, California. 'They aren't life-threatening in themselves, but they occasionally dislodge and go to the lungs,' he says. This is called a pulmonary embolism. Related: With a pulmonary embolism, a blood clot gets stuck in an artery in the lung and blocks blood flow to part of the lung, Dr. Yi explains. There, it can cause permanent damage to the lungs, low oxygen levels in your blood, and damage to other organs in your body (from not getting enough oxygen), he says, adding, 'This can be life-threatening." The Silent Sign of Blood Clots To Know About, According to a Vascular Surgeon Back to that silent symptom: Shortness of breath is common with pulmonary embolisms. 'Shortness of breath is a hallmark symptom of pulmonary embolism because of how the condition affects the lungs and oxygen delivery,' Dr. Parson says. 'The blocked artery prevents blood from reaching parts of the lung, so oxygen can't be absorbed into the bloodstream efficiently, resulting in shortness of breath.' This blockage usually comes on suddenly, so the body doesn't have time to compensate for the lower-than-usual oxygen, he explains. That can lead to sudden and intense shortness of breath. Related: When Shortness of Breath Is a Sign of a Blood Clot Shortness of breath can also be a sign of a slew of other things, including being out of shape, having asthma or just having a cold, making this a tricky thing to pin on a blood clot. But doctors say there are a few key differences between 'regular' shortness of breath and feeling breathless due to a blood clot.'Standard shortness of breath usually comes with exercise or activity,' Dr. Yi says. 'With a blood clot, there is a sudden onset of shortness of breath where you feel like you can't catch your breath.' You may also start breathing faster than usual, he explains. Along with coming on hard and fast, shortness of breath from a blood clot tends to get worse with exertion or taking deep breaths, according to Dr. Other Signs of a Blood Clot and What To Do While sudden shortness of breath alone should raise concerns about a possible pulmonary embolism, there are other blood clot symptoms doctors warn should be on your radar: Fast breathing Chest pain (it usually gets worse when you cough or take a deep breath) A faster-than-usual heart rate Coughing, including coughing up blood Very low blood pressure Feeling lightheaded Fainting It can be tempting to write these signs off if you have one or two that can be explained away as something more minor. But doctors stress the importance of taking these seriously if you or someone around you has them. 'If someone experiences these symptoms, immediate medical attention is critical,' Dr. Parsons says. Up Next:Sources: How Does Blood Clot? National Heart, Lung, and Blood Institute Data and Statistics on Venous Thromboembolism, Centers for Disease Control and Prevention Dr. Christopher Yi, MD, a vascular surgeon at MemorialCare Orange Coast Medical Center in Fountain Valley, CA Pulmonary Embolism. US National Library of Medicine Dr. Jonathan Parsons, MD, a pulmonologist at The Ohio State University Wexner Medical Center The Silent Symptom That Could Be a Sign of Blood Clots first appeared on Parade on Jul 27, 2025 This story was originally reported by Parade on Jul 27, 2025, where it first appeared. Solve the daily Crossword
